5,0
11 apr 2018
Dipendente attuale, meno di un anno
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Great people, extensive knowledge and skills in the more challenging pharma areas, like sterile injectable. Ability to work on many different drugs/products. New CEO is bringing needed operational and process excellence, which will position AMRI for big growth potential in the future.
Svantaggi
A lot of acquisitions that are not yet integrated. As mentioned in pro's- leadership recognizes the need for integration and process and operational work, which is getting underway, but will take some time.